GHP May 2017

GHP / May 2017 13 GELITA – Improving Quality of Life g to the elderly and also to an increasing number of physically active persons who have an interest in keeping in good shape and health. The latest study 6 in this field investigated the impact of Bioactive Collagen Peptides® on postmenopausal healthy women suffering from osteopenia or milder forms of osteoporosis. During this single-centre, prospective, randomised, double- blind, placebo-controlled trial, 180 healthy women with a bone mineral density ≤ -1 and ≥ -2.5 T-value were treated with 5 g of Bioactive Collagen Peptides® (FORTIBONE®) daily during a time period of 12 months. As a primary outcome of the